Fabbri L M, Hendrick D J, Diem J E
J Allergy Clin Immunol. 1983 May;71(5):468-72. doi: 10.1016/0091-6749(83)90463-3.
To determine whether atropine provides protection against the bronchoconstriction that develops in asthmatic subjects after inhalation of ultrasonically nebulized distilled water, we exposed six asthmatic patients to this stimulus with and without pretreatment with atropine (0.04 mg/kg). The mean FEV1 decreased from 3.32 to 2.39 L (-28%) without and from 3.49 to 3.18 L (-9%) with atropine. This protective effect was statistically significant (p less than 0.05), suggesting that cholinergic pathways are involved in the obstructive response to the inhalation of ultrasonically nebulized distilled water.
为了确定阿托品是否能预防哮喘患者吸入超声雾化蒸馏水后发生的支气管收缩,我们让6名哮喘患者在吸入超声雾化蒸馏水时分别接受和不接受阿托品(0.04mg/kg)预处理。未用阿托品时,平均第一秒用力呼气量(FEV1)从3.32L降至2.39L(下降28%);使用阿托品时,FEV1从3.49L降至3.18L(下降9%)。这种保护作用具有统计学意义(p<0.05),提示胆碱能途径参与了对吸入超声雾化蒸馏水的阻塞性反应。